In the global battle against illicit drugs, stemming the crisis of opioid dependence poses a grave challenge.

The World Health Organization (WHO) is issuing guidelines to help countries treat dependence on opioids and prevent the transmission of HIV and other blood-borne infections.

Mental health is something that affects all of us. When our mental health is good we have the foundation to handle the demands and challenges of daily life. However, when our mental health is not so good we may feel depressed and our ability to function effectively may be compromised.

In the Government of Canada’s publication The Human Face of Mental Health and Mental Illness in Canada, mental health is described as “the capacity of each and all of us to feel, think, and act in ways that enhance our ability to enjoy life and deal with the challenges we face.” This is different from mental illnesses that are defined as being “characterized by alterations in thinking, mood or behaviour — or some combination thereof — associated with significant distress and impaired functioning.”

On average, 8.5 percent of adolescents aged 12 to 17 described having had a major depressive episode in the previous year, the Substance Abuse and Mental Health Services Administration reported.

But there were “striking differences” by sex, with 12.7 percent of girls and 4.6 percent of boys affected.

Women with PPD usually respond to pharmacotherapy, but antidepressants’ potential effects on a nursing mother’s newborn are important to consider.

HPA axis dysregulation

Although the precise cause of PPD remains unclear, a better understanding is emerging of the complicated interplay of estrogen and progesterone with the hypothalamic-pituitary-adrenal (HPA) axis and other neuroregulatory systems associated with depressive illness. Two lines of evidence implicate hormonal dysregulation:

You’re not alone if you hesitate to prescribe hypnotics to these patients; a study of 311 addiction medicine physicians found that they prescribed sleep-promoting medication to only 30% of their alcohol-dependent patients with insomnia.

This article presents evidence on how alcohol and other substances disturb sleep in patients with addictions. We discuss the usefulness of hypnotics, off-label sedatives, and cognitive-behavioral therapy (CBT). Our goal is to help you reduce your patients’ risk of relapse by addressing their sleep complaints.

It is often not appreciated that the last decade of genetic studies in schizophrenia has generated findings suggesting that a number of genes are associated with schizophrenia across multiple studies (2). Not all studies of any particular gene are positive, and the contribution toward risk that any individual gene makes appears to be small. Many are also surprised that some of these genes were initially found using positional cloning, the systematic identification and localization of genes using linkage analysis in families segregating schizophrenia. Examples of such genes include dystrobrevin-binding protein 1 (DTNBP1), neuregulin 1 (NRG1), and D-amino acid oxidase activator (DAOA). Similarly, positive studies have emerged for genes pursued after being found at sites of chromosomal abnormalities. Disrupted in schizophrenia 1 (DISC1) was identified at the site of a chromosomal translocation segregating with schizophrenia (and other mental disorders) in a single pedigree. Likewise, the catechol-O-methyltransferase (COMT) gene occurs in a large common deletion of a segment of chromosome 22 that by itself increases the risk of schizophrenia by greater than 20-fold. Sanders et al. (1) chose to examine these genes as well as those connected to animal models (PP3CC, also residing in a reported linkage region) or pharmacological hypotheses (HTR2A, DRD2) in their analyses. This study stands above others because the authors attempt to bring to bear two critical factors on their experiment—a large sample and comprehensive genotyping.

The most troublesome issue related to pediatric use of antidepressants has been warnings about increases in suicidal ideation and behavior in youths and young adults treated with selective serotonin reuptake inhibitors. No compelling data are available to indicate whether the net result of treatment of depressed youths with these compounds is an overall increase or an overall decrease in the hazard of completed suicide; there is limited but inconclusive evidence in each direction (3).

Clinicians will therefore be pleased to learn that continuation treatment with fluoxetine was found to prevent relapse of major depression in youths in a well-designed randomized controlled trial of good size. Of course, this is what virtually all clinicians were already doing based on common sense, clinical experience, and extrapolation from adult studies, and on this occasion our common sense has served our patients well.

Bipolar disorder is characterized by distinct periods of elevated mood and euphoria (known as mania) followed by periods of sometimes agonizing depression. In mania, extreme creativity is not uncommon, and it is believed that many brilliant people in history may have suffered from the illness. In times of depression, victims often suffer through intense sorrow, hallucinations, disembodied voices, disconnect with reality, and uncontrollable fixations on death. Because of the debilitating nature of the disease, voices of support are loud and passionate in support of a potentially new way to treat it.

The study was based on telephone interviews conducted from August 2007 to January with 1,965 soldiers who have served in Iraq or Afghanistan, in some cases more than once. The soldiers interviewed live in 24 communities with high concentrations of service members, reservists and veterans. Researchers also conducted focus groups. About 1.6 million people have served in Iraq or Afghanistan in the past five years (Alvarez, New York Times, 4/18).

In total, 31% of Iraq and Afghanistan soldiers have experienced a brain injury, stress disorder, or both, the report found. The study found that 19.5% of service members experienced a concussion or other traumatic brain injury during their service (Barnes, Los Angeles Times, 4/18). Of soldiers who reported having a traumatic brain injury, 43% were evaluated by a physician. The report also found that about 7% of soldiers surveyed have a probable brain injury and currently have PTSD. PTSD and major depression were most prevalent in women and reservists, according to the report (Jelinek, AP/Miami Herald, 4/18). The treatment costs for brain injuries have not been determined, but according to the report, based on the number of traumatic brain injury cases diagnosed through June 2007, the cost is expected to be between $600 million and $900 million.

Although most of us now live long lives, we are well aware that we face new health challenges in the 21st century. In-depth community studies report that we all realise that the big gaps are in child health, mental health and Indigenous health. Thankfully, we now have a Prime Minister who has set real goals for closing the gap in Indigenous health. He has followed this up with his most recent announcement supporting high quality child care and early health and education initiatives.

Twenty-five per cent of all health-related disability under the age of 14 is due to mental health problems. This rises to 60 per cent for 15 to 34 year olds. Overall 75 per cent of all adult mental disorders commence before age 25. Eight out of ten of the major causes of premature death or disability in teenage boys are mental health or substance abuse conditions. That is, if you really want to know what health problems will result in your child dropping out of school, failing to go on to adult employment or living a socially chaotic life in the 21st century the answer is simply mental health or substance abuse. Most of this has its roots in childhood and early adolescence.

Executive Director of Narconon Drug Rehab, Mary Rieser warns, “We are seeing an alarming number of new students coming in addicted to heroin.  The drug has grown in popularity amongst today’s youth.  Heroin is the most common addiction we are now seeing among the addicts arriving at our rehab for treatment and rehabilitation.”

The DEA says that heroin is the most abused of all the opiates.  Heroin is common in all metropolitan areas on the east coast.  Heroin can vary in color from a white to darkish brown powder.  The darker the color the more additives the heroin has, such as fentanyl, strychnine, or other poisons. 

More money is spent on alcohol advertising than on any other product.  (What most people forget is that alcohol is the most widely abused drug on the planet.)

Alcohol addiction is one of the toughest to overcome, especially with televisions making alcohol look tasty, sensuous, sexy, or even smart.  (The irony here is that if you have a drunk person, they are none of these things.  How is a stumbling and slurring person who has had too much to drink sexy or smart?)

Fact of the matter, such a mood or psychiatric problem can have a heavy hand in the development of an addiction.  The chemical imbalances of the central nervous system, when a disorder is present, can make the individual susceptible to the influences of drugs and alcohol.  If gone undiagnosed, a person can turn to drugs and alcohol to suppress these feelings. These are feelings that the disorder itself is the cause of.  If it is diagnosed, drugs may be the self medicating solution to suppress these feelings.  A medical solution would ultimately be most effective at this stage.  The sad thing, unbeknownst to the individual suppressing their disorder, is they are developing a compound problem.  In addition to a psychiatric condition, the person has also developed an addiction to drugs and alcohol.

Methods: Systematic review of all evidence reporting the management and subsequent outcome in FD. Data were extracted and outcomes were assessed using an adaptation of the Global Improvement Scale.

But a spate of recent announcements from federal health officials suggests a surprising new interpretation of suicidal fantasies and the depression they are thought to signal: Sometimes, sadness, anxiety and self-destructive thoughts are not symptoms but side effects—of medicine.

In this year alone, federal regulators have warned that a surprising array of drugs could play a role in spurring thoughts of self-destruction. Medicines that treat epilepsy, asthma and influenza are now under suspicion, as is one that helps smokers kick the tobacco habit.